Statins and tissue mineralization: putative involvement of alkaline phosphatase

Medical Hypotheses
Maria R NegrãoMaria J Martins

Abstract

Many clinical trials have clearly demonstrated the benefit of statins in the prevention of coronary heart disease. Although other effects have subsequently been described, the so-called pleiotropic effects of statins, there is a tendency to relate all those effects, more or less directly, to inhibition of 3-hydroxy-3-methylglutaryl coenzyme A. Several clinical and laboratory studies show an association between statins and increased bone formation and/or density, but no clear explanation for that statin effect has emerged. We therefore hypothetized that statins may have an effect on alkaline phosphatase activity (ALP), an enzyme with an important role in bone mineralization and that may also contribute to pathological mineralization in other tissues, such as vascular calcification. Our experience with drug effects on ALP lead us to admit the possibility of finding a statin with an ALP increasing effect on bone but not on vascular tissue, or with a more marked effect upon one of the ALP isoforms or isoenzymes. That information would allow the design of clinical trials to confirm the suitability of a specific statin to a specific clinical condition.

References

Mar 8, 1971·JAMA : the Journal of the American Medical Association·T Gordon, W B Kannel
Apr 1, 1981·Canadian Journal of Physiology and Pharmacology·C PetitClerc, G E Plante
Oct 15, 1995·Circulation·L L Demer
Jan 1, 1994·Critical Reviews in Clinical Laboratory Sciences·V O Van Hoof, M E De Broe
Mar 1, 1997·Developmental Dynamics : an Official Publication of the American Association of Anatomists·S NarisawaJ L Millán
May 8, 1998·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·F MartelI Azevedo
Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Apr 22, 1999·Clinical Biochemistry·C CalhauI Azevedo
Jan 2, 2003·Nature Reviews. Drug Discovery·Brian P Zambrowicz, Arthur T Sands
Jan 22, 2004·Circulation·Gabriele A M PlenzHorst Robenek
Apr 3, 2004·Nature Reviews. Drug Discovery·Bryan L RothWesley K Kroeze
May 28, 2004·Metabolism: Clinical and Experimental·Graziana LupattelliElmo Mannarino
Jun 19, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Heiner K BertholdIoanna Gouni-Berthold
Nov 9, 2004·Atherosclerosis. Supplements·T R PedersenUNKNOWN Scandinavian Simvastatin Survival Study Group
Dec 29, 2004·The British Journal of Oral & Maxillofacial Surgery·Ricky W K Wong, A Bakr M Rabie
Mar 15, 2005·FEBS Letters·Andreas Wagner
May 4, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Hamit Alper TanriverdiSelda Sarikaya
Jun 10, 2005·The New England Journal of Medicine·S Joanna CowellUNKNOWN Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators
Jul 23, 2005·Current Osteoporosis Reports·Richard W Keen
Sep 30, 2005·Nature·Avigdor Eldar, Michael Elowitz

❮ Previous
Next ❯

Citations

Jan 19, 2012·International Journal of Biological Sciences·Feifei SuQiangsun Zheng
Apr 22, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Evelien NolletViviane O M Van Hoof
Dec 22, 2007·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·J FernandesM J Martins
Aug 23, 2008·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A MotaM J Martins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

JAMA : the Journal of the American Medical Association
L Kristin NewbySYMPHONY and 2nd SYMPHONY Investigators. Sibrafiban vs Aspirin to Yield Maximun Protection From Ischemic Heart Events Post-a
Cardiovascular Drugs and Therapy
Andrea CignarellaR Paoletti
Oral Diseases
N Horiuchi, T Maeda
© 2022 Meta ULC. All rights reserved